NEW YORK CITY, NY / ACCESS Newswire / May 29, 2025 / In a world that increasingly values health, appearance, and performance, finding the right weight-loss solution has never been more crucial-or more ...

BETHLEHEM, Pa. -- The FDA says off-brand weight loss injection medications are sending people to the hospital. There's confusion surrounding changing doses, injection tools and measurements.

Amid volatile trade and rising uncertainty, these momentum stocks have shown strong signs of leadership in the first half of ...

As pet insurance coverage increases and consumers demand higher standards of care, the veterinary dermatology drugs market is set to grow steadily. INDORE, INDIA, May 21, 2025 /EINPresswire.com/ -- ...

FDA approved Merck's Welireg as the first oral therapy for advanced pheochromocytoma or paraganglioma (PPGL). In the LITESPARK-015 trial, Welireg showed a 26% ORR and a 20.4-month median duration ...

Natural Chromium Picolinate- this ingredient helps you control hunger and food cravings. Additionally, it makes your system more sensitive to insulin. Nopal cactus- this is the best appetite ...

The U.S. FDA is removing concentrated fluoride prescription drugs for children from the market. Unlike fluoride toothpaste or rinses, which are consumed by infants and toddlers, these products ...

People taking Eli Lilly's obesity drug, Zepbound, lost nearly 50% more weight than those using rival Novo Nordisk's Wegovy in the first head-to-head study of the blockbuster medications. Clinical ...

In the wake of mass restructuring efforts across the Department of Health and Human Services (HHS), the FDA has missed yet another approval decision target date. GSK had expected to secure an FDA ...

The FDA has appointed its first chief artificial intelligence officer, with an eye on supporting the agency’s internal IT systems and potentially accelerating its reviews of medical products.

Fired workers from the Division of Drug Information, which conducts safety monitoring, say the DDI team lost between 75% and 90% of its roughly 50-person staff in the FDA’s April 1 reduction in ...

"Any delays in drug approvals are the result of the FDA’s rigorous review process, which is designed to ensure that all medications are safe and effective for the American people," the ...